PULMONARY ALVEOLAR PROTEINOSIS - A case report
Abstract
Pulmonary alveolar proteinosis is a very rare disorder. We report a case who presented with complaints of progressively worsening dyspnea. Her chest x-ray showed bilateral diffuse alveolar opacities. CT scan of the thorax showed a typical crazy paving appearance. Bronchoalveolar lavage showed PAS positive material confirming the diagnosis of pulmonary alveolar proteinosis. She underwent 3 sittings of whole lung lavage under general anesthesia following which she recovered completely and has been recurrence free.
Full Text:
PDFReferences
Ben-Dov I, Segel MJ. Autoimmune pulmonary alveolar proteinosis: clinical course and diagnostic criteria. Autoimmun Rev. 2014 May;13(4-5):513–7.
Inoue Y, Nakata K, Arai T, Tazawa R, Hamano E, Nukiwa T, et al. Epidemiological and clinical features of idiopathic pulmonary alveolar proteinosis in Japan. Respirol Carlton Vic. 2006 Jan;11 Suppl:S55–60.
Leth S, Bendstrup E, Vestergaard H, Hilberg O. Autoimmune pulmonary alveolar proteinosis: treatment options in year 2013. Respirol Carlton Vic. 2013 Jan;18(1):82–91.
Bonella F, Campo I. Pulmonary alveolar proteinosis. Pneumologia. 2014 Sep;63(3):144, 147–55.
Beccaria M, Luisetti M, Rodi G, Corsico A, Zoia MC, Colato S, et al. Long-term durable benefit after whole lung lavage in pulmonary alveolar proteinosis. Eur Respir J. 2004 Apr;23(4):526–31.
Zhou X, Lu G, Yu Z, Gao F, Bian T. Long-term follow-up of whole lung lavage in patients with pulmonary alveolar proteinosis. Exp Ther Med. 2014 Sep;8(3):763–8.
Tazawa R, Inoue Y, Arai T, Takada T, Kasahara Y, Hojo M, et al. Duration of benefit in patients with autoimmune pulmonary alveolar proteinosis after inhaled granulocyte-macrophage colonystimulating
factor therapy. Chest. 2014 Apr;145(4):729–37.
Tazawa R, Trapnell BC, Inoue Y, Arai T, Takada T, Nasuhara Y, et al. Inhaled granulocyte/macrophage-colony stimulating factor as therapy for pulmonary alveolar proteinosis. Am J Respir Crit Care Med. 2010 Jun 15;181(12):1345–54.
Venkateshiah SB, Yan TD, Bonfield TL, Thomassen MJ, Meziane M, Czich C, et al. An openlabel trial of granulocyte macrophage colony stimulating factor therapy for moderate symptomatic pulmonary alveolar proteinosis. Chest. 2006 Jul;130(1):227–37.
Yu H yan, Sun X feng, Wang Y xun, Xu Z jun, Huang H. Whole lung lavage combined with Granulocyte-macrophage colony stimulating factor inhalation for an adult case of refractory pulmonary alveolar proteinosis. BMC Pulm Med. 2014;14:87.
Amital A, Dux S, Shitrit D, Shpilberg O, Kramer MR. Therapeutic effectiveness of rituximab in a patient with unresponsive autoimmune pulmonary alveolar proteinosis. Thorax. 2010 Nov;65(11):1025–6.
Kavuru MS, Malur A, Marshall I, Barna BP, Meziane M, Huizar I, et al. An open-label trial of rituximab therapy in pulmonary alveolar proteinosis. Eur Respir J. 2011 Dec;38(6):1361–7.
Khan A, Agarwal R, Aggarwal AN, Bal A, Sen I, Yaddanapuddi LN, et al. Experience with treatment of pulmonary alveolar proteinosis from a tertiary care centre in north India. Indian J Chest Dis Allied Sci. 2012 Jun;54(2):91–7.
Refbacks
- There are currently no refbacks.
This work is licensed under a Creative Commons Attribution-NoDerivatives 4.0 International License.
An initiative of The Tamil Nadu Dr M.G.R. Medical University